Page last updated: 2024-08-21

2,6-dichloroindophenol and Breast Cancer

2,6-dichloroindophenol has been researched along with Breast Cancer in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Azimian, SM; Bair, WB; Cabello, CM; Davis, AL; Lamore, SD; Wondrak, GT1

Other Studies

1 other study(ies) available for 2,6-dichloroindophenol and Breast Cancer

ArticleYear
DCPIP (2,6-dichlorophenolindophenol) as a genotype-directed redox chemotherapeutic targeting NQO1*2 breast carcinoma.
    Free radical research, 2011, Volume: 45, Issue:3

    Topics: 2,6-Dichloroindophenol; Animals; Antineoplastic Agents; Breast Neoplasms; Caspases; Cell Death; Cell Line, Tumor; Cell Proliferation; DNA Damage; Female; Flow Cytometry; Gene Expression Regulation, Neoplastic; Glutathione; Heat-Shock Proteins; Humans; Immunoblotting; Membrane Potential, Mitochondrial; Mice; NAD(P)H Dehydrogenase (Quinone); Oxidative Stress; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; RNA, Small Interfering

2011